China Formulates Plan To Deepen Health Care Reform
This article was originally published in PharmAsia News
Executive Summary
According to the National Development and Reform Commission, China is formulating an overall plan for deepening its health care reform. The central government will continue to allocate budget to support and equip health care system establishments in the countryside, upgrading or setting up new township health centers, county-level hospitals, TCM hospitals, as well as women's and children's health care organizations. The rural three-tier health network is being improved, with new cooperative medical care systems covering such areas around the country. More than 800 million rural residents have participated in the program. In addition, central finance has doubled subsidies for the central and western regions, with basic health insurance covering close to 60 million town dwellers. (Click here for more - Chinese Language)
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.